Chrissy M. Leopold Wager
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Chrissy M. Leopold Wager has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Larry S. Schlesinger
Texas Biomedical Research Institute, San Antonio, TX, USA
2 shared publications - Adrian A. Naoun
Department of Clinical Sciences, San Juan Bautista School of Medicine, Caguas, Puerto Rico; Division of Cardiology, Department of Medicine, Heart and Vascular Institute, Brigham and Women's Hospital, Mass General Brigham and Harvard Medical School, Boston, Massachusetts, USA
1 shared publication Eusondia Arnett
Affiliation Host Pathogen Interaction Program, Texas Biomedical Research Institute, San Antonio, Texas, United States of America
1 shared publication- Eusondia Arnett
Texas Biomedical Research Institute, San Antonio, TX, USA
1 shared publication Jan Simper
Affiliations Host Pathogen Interaction Program, Texas Biomedical Research Institute, San Antonio, Texas, United States of America, Medical Scientist Training Program, Department of Microbiology, Immunology and Molecular Genetics, UT Health Science Center San Antonio, San Antonio, Texas, United States of America
1 shared publicationJordan R. Bonifacio
Affiliation Host Pathogen Interaction Program, Texas Biomedical Research Institute, San Antonio, Texas, United States of America
1 shared publication
Latest Publications
- Open Access
- 31 March 2023
- Published by Public Library of Science (PLoS) in PLOS Pathogens
- Vol. 19 (3) , e1011297
Activation of transcription factor CREB in human macrophages by Mycobacterium tuberculosis promotes bacterial survival, reduces NF-kB nuclear transit and limits phagolysosome fusion by reduced necroptotic signaling
Macrophages are a first line of defense against pathogens. However, certain invading microbes modify macrophage responses to promote their own survival and growth. Mycobacterium tuberculosis (M.tb) is a human-adapted intracellular pathogen that exploits macrophages as an intracellular niche. It was previously reported that M.tb rapidly activates cAMP Response Element Binding Protein (CREB), a transcription factor that regulates diverse cellular responses in macrophages. However, the mechanism(s) underlying CREB activation and its downstream roles in human macrophage responses to M.tb are largely unknown. Herein we determined that M.tb-induced CREB activation is dependent on signaling through MAPK p38 in human monocyte-derived macrophages (MDMs). Using a CREB-specific inhibitor, we determined that M.tb-induced CREB activation leads to expression of immediate early genes including COX2, MCL-1, CCL8 and c-FOS, as well as inhibition of NF-kB p65 nuclear localization. These early CREB-mediated signaling events predicted that CREB inhibition would lead to enhanced macrophage control of M.tb growth, which we observed over days in culture. CREB inhibition also led to phosphorylation of RIPK3 and MLKL, hallmarks of necroptosis. However, this was unaccompanied by cell death at the time points tested. Instead, bacterial control corresponded with increased colocalization of M.tb with the late endosome/lysosome marker LAMP-1. Increased phagolysosomal fusion detected during CREB inhibition was dependent on RIPK3-induced pMLKL, indicating that M.tb-induced CREB signaling limits phagolysosomal fusion through inhibition of the necroptotic signaling pathway. Altogether, our data show that M.tb induces CREB activation in human macrophages early post-infection to create an environment conducive to bacterial growth. Targeting certain aspects of the CREB-induced signaling pathway may represent an innovative approach for development of host-directed therapeutics to combat TB.
- 31 March 2023
- Published by Public Library of Science (PLoS) in PLOS Pathogens
- Vol. 19 (3) , e1011297
Open AccessActivation of transcription factor CREB in human macrophages by Mycobacterium tuberculosis promotes bacterial survival, reduces NF-kB nuclear transit and limits phagolysosome fusion by reduced necroptotic signaling
Macrophages are a first line of defense against pathogens. However, certain invading microbes modify macrophage responses to promote their own survival and growth. Mycobacterium tuberculosis (M.tb) is a human-adapted intracellular pathogen that exploits macrophages as an intracellular niche. It was previously reported that M.tb rapidly activates cAMP Response Element Binding Protein (CREB), a transcription factor that regulates diverse cellular responses in macrophages. However, the mechanism(s) underlying CREB activation and its downstream roles in human macrophage responses to M.tb are largely unknown. Herein we determined that M.tb-induced CREB activation is dependent on signaling through MAPK p38 in human monocyte-derived macrophages (MDMs). Using a CREB-specific inhibitor, we determined that M.tb-induced CREB activation leads to expression of immediate early genes including COX2, MCL-1, CCL8 and c-FOS, as well as inhibition of NF-kB p65 nuclear localization. These early CREB-mediated signaling events predicted that CREB inhibition would lead to enhanced macrophage control of M.tb growth, which we observed over days in culture. CREB inhibition also led to phosphorylation of RIPK3 and MLKL, hallmarks of necroptosis. However, this was unaccompanied by cell death at the time points tested. Instead, bacterial control corresponded with increased colocalization of M.tb with the late endosome/lysosome marker LAMP-1. Increased phagolysosomal fusion detected during CREB inhibition was dependent on RIPK3-induced pMLKL, indicating that M.tb-induced CREB signaling limits phagolysosomal fusion through inhibition of the necroptotic signaling pathway. Altogether, our data show that M.tb induces CREB activation in human macrophages early post-infection to create an environment conducive to bacterial growth. Targeting certain aspects of the CREB-induced signaling pathway may represent an innovative approach for development of host-directed therapeutics to combat TB.
- 1 May 2019
- Published by Elsevier in Tuberculosis
- Vol. 116, S98-S106
Mycobacterium tuberculosis and macrophage nuclear receptors: What we do and don't know
- 1 May 2019
- Published by Elsevier in Tuberculosis
- Vol. 116, S98-S106
Mycobacterium tuberculosis and macrophage nuclear receptors: What we do and don't know